Cancer-initiating cells that launch glioblastoma multiforme, the most lethal type of brain tumor, also suppress an immune system attack on the disease, scientists from The teaching hospital of Texas M. D. Anderson Cancer Center report in a paper be featured on the cover of the Jan. 15 issue of Clinical Cancer Research. The researchers demonstrate that this subset of tumor cells, also known as cancer stem cells, stifles the immune retroaction in a variety of ways, but that the effect can be greatly diminished by likely the stem cells to differentiate into other types of brain cell...

More: - From the site